LOS ANGELES — In this Healio Video Perspective, Mark Papini of Sight Sciences overviews the Omni Edge Surgical System for glaucoma, which debuted at the ASCRS meeting.
According to Papini, the Omni Edge’s TruSync technology enables the “safe, reproducible and predictable” deployment of viscoelastic fluid into Schlemm’s canal. It has been used in more than 300,000 cases and has shown positive results as both a stand-alone treatment and in combination with cataract surgery.
The system acts as a “comprehensive” option that treats the three resistance